TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

Primary carcinomas from 46 patients were screened for TP53 alterations. Immunohistochemistry demonstrated nuclear TP53 protein accumulation in 22 (48%) cases using the polyclonal CM1 antiserum, whereas 15 (33%) cases showed positive nuclear staining with the mononuclear antibody PAb 1801. Constant d...

Full description

Bibliographic Details
Main Authors:	Skomedal, H., Kristensen, G., Helland, A., Nesland, J. M., Kooi, S., Børresen, A. L., Holm, R.
Format:	Online
Language:	English
Published:	1995
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034131/

Similar Items

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
by: Helland, A., et al.
Published: (1998)

Prognostic significance of TP53 alterations in breast carcinoma.
by: Andersen, T. I., et al.
Published: (1993)

TP53 allele loss, mutations and expression in malignant melanoma.
by: Flørenes, V. A., et al.
Published: (1994)

TP53 mutations among molecular subtypes of HER2-positive tumors
by: Helland, Å, et al.
Published: (2005)

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
by: Kringen, Pedro, et al.
Published: (2005)

P53 mutations in gastric carcinomas.
by: Seruca, R., et al.
Published: (1992)

Expression of wild-type and mutated TP53 in breast carcinomas
by: Baumbusch, LO, et al.
Published: (2005)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
by: Langerød, A, et al.
Published: (2000)

Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas
by: Dai, Haiyan, et al.
Published: (2001)

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
by: Halvorsen, Ann R., et al.
Published: (2016)

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway
by: Joshi, H, et al.
Published: (2012)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
by: Langerød, A, et al.
Published: (2005)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
by: Leroy, Bernard, et al.
Published: (2013)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
by: Andersen, TI, et al.
Published: (2000)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
by: Kyndi, M, et al.
Published: (2005)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
by: Loeb, Keith R., et al.
Published: (2012)

Evaluation of the arrayed primer extension resequencing assay for TP53 mutation detection
by: Due, EU, et al.
Published: (2005)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
by: Langerød, Anita, et al.
Published: (2007)

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
by: Ahmed, Ahmed Ashour, et al.
Published: (2010)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
by: McGraw, K L, et al.
Published: (2015)

The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
by: Brachova, Pavla, et al.
Published: (2013)

TP53 mutations on circulating cell-free DNA
by: Pantel, Klaus
Published: (2016)

Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis.
by: Abdel-Fattah, R., et al.
Published: (1998)

TP53/MicroRNA Interplay in Hepatocellular Carcinoma
by: Pollutri, Daniela, et al.
Published: (2016)

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.
by: Smith-Sørensen, B., et al.
Published: (1998)

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
by: Köbel, Martin, et al.
Published: (2016)

The TP53 fertility network
by: Paskulin, Diego d’Avila, et al.
Published: (2012)

TP53: an oncogene in disguise
by: Soussi, T, et al.
Published: (2015)

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
by: Munch-Petersen, Helga D., et al.
Published: (2016)

Human papillomavirus DNA and TP53 mutations in lung cancers from butchers.
by: al-Ghamdi, A. A., et al.
Published: (1995)

The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables.
by: Meling, G. I., et al.
Published: (1993)

The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.
by: Meling, G. I., et al.
Published: (1993)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
by: Sonkin, Dmitriy
Published: (2015)

Germline TP53 mutational spectrum in French Canadians with breast cancer
by: Arcand, Suzanna L, et al.
Published: (2015)

The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML
by: Wong, Terrence N., et al.
Published: (2014)

TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts
by: Kucab, Jill E., et al.
Published: (2015)

The R337H mutation in TP53 and breast cancer in Brazil
by: Gomes, Magda CB, et al.
Published: (2012)

TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations
by: Abedi-Ardekani, Behnoush, et al.
Published: (2011)

TP53 mutations are infrequent in newly diagnosed chronic lymphocytic leukimia
by: Zainuddin, Norafiza, et al.
Published: (2011)

Is a TNF alpha polymorphism responsible for mutations in the TP53 gene?
by: Berglund, Mattias, et al.
Published: (2011)